Page 61 - NobleCon20-Book-Project

Electromed, Inc.

SELECTED FINANCIAL ITEMS ELMD

(in millions of USD)
CQ4 '23 CQ1 '24 CQ2 '24 CQ3 '24 LTM
Income Statement Key Items
Total Revenue 13.69 13.87 14.83 14.67 57.06
Gross Profit 10.55 10.38 11.30 11.49 43.72
Gross Margin 77% 75% 76% 78% 77%
EBIT 2.26 1.84 2.34 1.94 8.38
EBIT Margin 17% 13% 16% 13% 15%
Net Income to Common Shareholders 1.67 1.49 1.83 1.47 6.47
Net Margin 12% 11% 12% 10% 11%

Balance Sheet Key Items
Total Assets 46.96 48.90 52.23 48.92 48.92
Cash & Short Term Investments 10.43 11.71 16.08 13.86 13.86
% of Assets 22% 24% 31% 28% 28%
Current Assets -Total 39.27 41.32 44.17 41.01 41.01
% of Assets 84% 85% 85% 84% 84%
Total Liabilities 6.62 6.36 7.69 7.43 7.43
% of Assets 14% 13% 15% 15% 15%
Current Liabilities - Total 6.57 6.33 7.68 7.42 7.42
% of Assets 14% 13% 15% 15% 15%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity 40.34 42.54 44.55 41.49 41.49
% of Assets 86% 87% 85% 85% 85%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities 3.47 1.35 4.49 2.31 11.62
Net Cash Flow - Investing (0.09) (0.13) (0.05) (0.06) (0.32)
Net Cash Flow - Financing 0.03 0.06 (0.08) (4.47) (4.46)

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twentieth Annual Small & Microcap Investor Conference